First, this study investigated the impact of LIT-927 treatment at a single concentration and duration of treatment; extensive dose- and time-response experiments are certainly warranted to more fully investigate the potential of CXCL12 neutralization as a therapy for allergic asthma. Here, CXCL12 is linked to allergic asthma.